CONDENSED COMBINED DEBTOR-IN-POSSESSION FINANCIAL INFORMATION-CONDENSED COMBINED STATEMENTS OF CASH FLOWS (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
OPERATING ACTIVITIES:
Net cash provided by operating activities	$ 320,041	$ 159,611
INVESTING ACTIVITIES:
Capital expenditures, excluding capitalized interest	(74,245)	(77,865)
Proceeds from the U.S. Government Agreement	32,560	13,601
Acquisitions, including in-process research and development, net of cash and restricted cash acquired	0	(89,520)
Proceeds from sale of business and other assets	3,538	22,378
Net cash used in investing activities	(38,147)	(134,546)
FINANCING ACTIVITIES:
Repayments of notes	0	(180,342)
Repayments of term loans	0	(10,000)
Adequate protection payments	(445,519)	(168,643)
Repayments of other indebtedness	(4,999)	(4,501)
Payments for contingent consideration	(4,353)	(1,939)
Payments of tax withholding for restricted shares	0	(1,898)
Net cash used in financing activities	(454,871)	(367,323)
Effect of foreign exchange rate	(20)	(4,674)
NET DECREASE IN CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS	(172,997)	(346,932)
CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS, BEGINNING OF PERIOD	1,249,241	1,631,310
CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS, END OF PERIOD	1,076,244	1,284,378
Debtor-in-Possession
OPERATING ACTIVITIES:
Net cash provided by operating activities	309,685	75,349
INVESTING ACTIVITIES:
Capital expenditures, excluding capitalized interest	(52,223)	(35,018)
Proceeds from the U.S. Government Agreement	32,560	13,601
Acquisitions, including in-process research and development, net of cash and restricted cash acquired	0	(89,520)
Proceeds from sale of business and other assets	3,538	22,378
Disbursements for loans made to Non-Debtor Affiliates	(25,243)	(51,180)
Other investing activities	0	0
Net cash used in investing activities	(39,780)	(139,739)
FINANCING ACTIVITIES:
Repayments of notes	0	(180,342)
Repayments of term loans	0	(10,000)
Adequate protection payments	(445,519)	(168,643)
Repayments of other indebtedness	(4,999)	(4,500)
Payments for contingent consideration	(4,353)	(1,939)
Payments of tax withholding for restricted shares	0	(1,898)
Net cash used in financing activities	(454,871)	(367,322)
Effect of foreign exchange rate	258	(2,393)
NET DECREASE IN CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS	(184,708)	(434,105)
CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS, BEGINNING OF PERIOD	1,136,259	1,568,698
CASH, CASH EQUIVALENTS, RESTRICTED CASH AND RESTRICTED CASH EQUIVALENTS, END OF PERIOD	951,551	1,134,593
Proceeds from loans made to Non-Debtor Affiliates	$ 1,588	$ 0

Endo International plc 10-Q